Latest Global Markets News

Page 31 of 42
Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.
Ada Torres
Ada Torres
12 May 2025
Dyno Nobel Limited reported a $25 million EBIT uplift in its 2025 half-year results, driven by its ongoing transformation program and strategic moves to separate its Fertilisers business. Despite weather-related challenges, the company is progressing key asset sales and preparing for a share buyback resumption.
Maxwell Dee
Maxwell Dee
12 May 2025
Dyno Nobel Limited reported a mixed half-year performance with a modest dip in revenues but a significant rise in net profit from continuing operations. The company is accelerating its transformation through major asset sales and a recommencement of its substantial share buyback program.
Maxwell Dee
Maxwell Dee
12 May 2025
Celsius Resources plans to issue additional free-attaching options to investors in its Tranche 2 Placement, aiming to bolster support amid challenging geopolitical and economic conditions. These options, exercisable at a nominal price, await shareholder approval and ASX listing conditions.
Maxwell Dee
Maxwell Dee
9 May 2025
Austco Healthcare has renewed its preferred supplier agreement with a major US healthcare provider, continuing supply of its Tacera nurse call systems to 180 hospitals across 30 states. This extension builds on a lucrative five-year partnership worth over A$49 million.
Ada Torres
Ada Torres
9 May 2025
Macquarie Group reported a 5% increase in net profit to A$3.7 billion for FY25, driven by strong asset management and banking results despite a dip in commodities. The group also extended its $2 billion share buyback and declared a solid final dividend.
Victor Sage
Victor Sage
9 May 2025
QBE Insurance Group reported robust 8% gross written premium growth in 1Q25, driven by strong momentum in North America and International markets, while managing significant catastrophe claims. The insurer reaffirmed its full-year outlook despite ongoing market challenges.
Victor Sage
Victor Sage
9 May 2025
Macquarie Bank Limited reported an 18% rise in net profit for FY2025, driven by growth in its retail banking segment despite margin pressures, while its commodities business faced subdued markets. The bank maintained strong capital ratios and advanced its risk and technology frameworks amid regulatory scrutiny.
Claire Turing
Claire Turing
9 May 2025
Macquarie Group Limited reported a 5% increase in net profit to A$3.715 billion for FY2025, driven by growth in asset management and banking segments alongside a robust capital and liquidity position.
Claire Turing
Claire Turing
9 May 2025
Macquarie Group reported a 5% rise in full-year net profit to A$3.715 billion for FY25, driven by growth across its diversified businesses and a solid capital position. The group’s assets under management reached A$941 billion, supported by strong home loan and deposit growth.
Claire Turing
Claire Turing
9 May 2025
Macquarie Group reported a 5% increase in full-year net profit to A$3.7 billion for FY25, driven by strong second-half growth and robust asset management performance. The company declared a final dividend of A$3.90 per share and extended its share buyback program.
Claire Turing
Claire Turing
9 May 2025
Macquarie Group Limited has posted a 5% increase in net profit for FY2025, driven by strong asset management and banking growth, while advancing its sustainability and digital innovation agenda.
Claire Turing
Claire Turing
9 May 2025